| human | Q5 |
| P6178 | Dimensions author ID | 01012434074.11 |
| P269 | IdRef ID | 073942170 |
| P213 | ISNI | 0000000359498416 |
| P496 | ORCID iD | 0000-0003-3362-2634 |
| P1053 | ResearcherID | O-1785-2017 |
| P214 | VIAF cluster ID | 217187274 |
| P184 | doctoral advisor | Yvan Touitou | Q3573389 |
| P185 | doctoral student | Caroline Schmitt | Q44115093 |
| P735 | given name | Hervé | Q18508906 |
| Hervé | Q18508906 | ||
| P106 | occupation | researcher | Q1650915 |
| P21 | sex or gender | male | Q6581097 |
| Q51229898 | A Variant of Peptide Transporter 2 Predicts the Severity of Porphyria-Associated Kidney Disease |
| Q83906737 | A homoallelic FECH mutation in a patient with both erythropoietic protoporphyria and palmar keratoderma |
| Q33402382 | A management algorithm for congenital erythropoietic porphyria derived from a study of 29 cases. |
| Q81333559 | A mouse model provides evidence that genetic background modulates anemia and liver injury in erythropoietic protoporphyria |
| Q28257493 | ABCB6 is dispensable for erythropoiesis and specifies the new blood group system Langereis |
| Q39001804 | Acute hepatic and erythropoietic porphyrias: from ALA synthases 1 and 2 to new molecular bases and treatments. |
| Q73830463 | Acute intermittent porphyria: prevalence of mutations in the porphobilinogen deaminase gene in blood donors in France |
| Q83938631 | Acute porphyric attack mimicking HIV-associated progressive polyradiculoneuropathy |
| Q47297822 | An uncommon option for surviving bariatric surgery: regaining weight! |
| Q51989552 | Analytical correlation between plasma N-terminal pro-brain natriuretic peptide and brain natriuretic peptide in patients presenting with dyspnea |
| Q44302301 | Ancestral founder of mutation W283X in the porphobilinogen deaminase gene among acute intermittent porphyria patients. |
| Q37693360 | Antisense oligonucleotide-based therapy in human erythropoietic protoporphyria |
| Q83120588 | Biochemical compared to molecular diagnosis in acute intermittent porphyria |
| Q36296712 | Cardiac iron overload in chronically transfused patients with thalassemia, sickle cell anemia, or myelodysplastic syndrome |
| Q84962888 | Comprehensive cytochrome P450 CYP1A2 gene analysis in French caucasian patients with familial and sporadic porphyria cutanea tarda |
| Q47362617 | Congenital erythropoietic porphyria: a single-observer clinical study of 29 cases. |
| Q34563770 | Contribution of a common single-nucleotide polymorphism to the genetic predisposition for erythropoietic protoporphyria |
| Q72877888 | Decreased nocturnal plasma melatonin levels in patients with recurrent acute intermittent porphyria attacks |
| Q71660356 | Detection of four novel mutations in the porphobilinogen deaminase gene in French Caucasian patients with acute intermittent porphyria |
| Q43137967 | Diagnostic accuracy of serum hepcidin for iron deficiency in critically ill patients with anemia |
| Q86801379 | Does IV Iron Induce Plasma Oxidative Stress in Critically Ill Patients? A Comparison With Healthy Volunteers |
| Q42986887 | Epidemiology of hepatitis C and G in sporadic and familial porphyria cutanea tarda. |
| Q44115012 | Epistasis in iron metabolism: complex interactions between Cp, Mon1a, and Slc40a1 loci and tissue iron in mice. |
| Q21202891 | Erythropoietic protoporphyria |
| Q74578948 | Evaluation of mutation screening by heteroduplex analysis in acute intermittent porphyria: comparison with denaturing gradient gel electrophoresis |
| Q77708979 | Exon 1 donor splice site mutations in the porphobilinogen deaminase gene in the non-erythroid variant form of acute intermittent porphyria |
| Q38961702 | Fecal calprotectin in inflammatory bowel diseases: update and perspectives. |
| Q62381825 | GNPATpolymorphism rs11558492 is not associated with increased severity in a large cohort ofHFEp.Cys282Tyr homozygous patients |
| Q40313066 | Gene Therapy in a Patient with Sickle Cell Disease |
| Q48081983 | Genetic study of variation in normal mouse iron homeostasis reveals ceruloplasmin as an HFE-hemochromatosis modifier gene. |
| Q74672840 | Heme and acute inflammation role in vivo of heme in the hepatic expression of positive acute-phase reactants in rats |
| Q37618819 | Hemolytic anemia repressed hepcidin level without hepatocyte iron overload: lesson from Günther disease model |
| Q41924085 | Hepatic porphyria |
| Q34509663 | Hepatocellular carcinoma in patients with acute hepatic porphyria: frequency of occurrence and related factors. |
| Q83417327 | Hepatocellular carcinoma without cirrhosis: think acute hepatic porphyrias and vice versa |
| Q36624644 | Hepcidin as a Major Component of Renal Antibacterial Defenses against Uropathogenic Escherichia coli |
| Q39161145 | Hepcidin regulates intrarenal iron handling at the distal nephron. |
| Q38818590 | Heterozygous Mutations in BMP6 Pro-peptide Lead to Inappropriate Hepcidin Synthesis and Moderate Iron Overload in Humans |
| Q41129067 | High prevalence of and potential mechanisms for chronic kidney disease in patients with acute intermittent porphyria |
| Q36068952 | Human Erythroid 5-Aminolevulinate Synthase Mutations Associated with X-Linked Protoporphyria Disrupt the Conformational Equilibrium and Enhance Product Release. |
| Q73713698 | Identification of a prevalent nonsense mutation (W283X) and two novel mutations in the porphobilinogen deaminase gene of Swiss patients with acute intermittent porphyria |
| Q37897173 | Immunological specificity of monoclonal antibodies to Chlamydia psittaci ovine abortion strain. |
| Q28590826 | Increased plasma transferrin, altered body iron distribution, and microcytic hypochromic anemia in ferrochelatase-deficient mice |
| Q31065488 | Influence of meteorological data on sun tolerance in patients with erythropoietic protoporphyria in France. |
| Q57397527 | Iron Regulatory Proteins Secure Mitochondrial Iron Sufficiency and Function |
| Q59590299 | Iron metabolism in patients with anorexia nervosa: elevated serum hepcidin concentrations in the absence of inflammation |
| Q41480174 | Iron regulatory protein 1 sustains mitochondrial iron loading and function in frataxin deficiency. |
| Q88093117 | Iron status and inflammatory biomarkers in patients with acutely decompensated heart failure: early in-hospital phase and 30-day follow-up |
| Q54163174 | Isoniazid inhibits human erythroid 5-aminolevulinate synthase: Molecular mechanism and tolerance study with four X-linked protoporphyria patients |
| Q33185658 | KDBI: Kinetic Data of Bio-molecular Interactions database. |
| Q41203826 | LC-MS/MS method for hepcidin-25 measurement in human and mouse serum: clinical and research implications in iron disorders. |
| Q85637833 | Late-onset X-linked dominant protoporphyria: an etiology of photosensitivity in the elderly |
| Q36694790 | Loss of heterozygosity on 10q and mutational status of PTEN and BMPR1A in colorectal primary tumours and metastases |
| Q46249700 | Melatonin and environmental lighting regulate ALA-S gene expression and So porphyrin biosynthesis in the rat harderian gland |
| Q42478276 | Mitochondrial energetic defects in muscle and brain of a Hmbs-/- mouse model of acute intermittent porphyria |
| Q44688689 | Modulation of penetrance by the wild-type allele in dominantly inherited erythropoietic protoporphyria and acute hepatic porphyrias. |
| Q40433955 | Molecular abnormalities of coproporphyrinogen oxidase in patients with hereditary coproporphyria. |
| Q54259545 | Molecular analysis of porphobilinogen (PBG) deaminase gene mutations in acute intermittent porphyria: first study in patients of Slavic origin. |
| Q85776162 | Molecular and functional analysis of the C-terminal region of human erythroid-specific 5-aminolevulinic synthase associated with X-linked dominant protoporphyria (XLDPP) |
| Q28272057 | Mutations in human CPO gene predict clinical expression of either hepatic hereditary coproporphyria or erythropoietic harderoporphyria |
| Q52531866 | Mutations in the ferrochelatase gene of four Spanish patients with erythropoietic protoporphyria. |
| Q73405777 | New mutations of the hydroxymethylbilane synthase gene in German patients with acute intermittent porphyria |
| Q77442187 | Nitric oxide synthase inhibition and the induction of cytochrome P-450 affect heme oxygenase-1 messenger RNA expression after partial hepatectomy and acute inflammation in rats |
| Q36843054 | Null alleles of ABCG2 encoding the breast cancer resistance protein define the new blood group system Junior |
| Q57782438 | Performance of PIVKA-II for early hepatocellular carcinoma diagnosis and prediction of microvascular invasion |
| Q45290780 | Plasma N-terminal pro-brain natriuretic peptide and brain natriuretic peptide in assessment of acute dyspnea |
| Q28291727 | Porphobilinogen deaminase gene structure and molecular defects |
| Q40972094 | Porphyrias and haem related disorders |
| Q38542777 | Porphyrias: A 2015 update |
| Q46838872 | Pro-oxidant effect of ALA is implicated in mitochondrial dysfunction of HepG2 cells. |
| Q84564481 | Protoporphyrin retention in hepatocytes and Kupffer cells prevents sclerosing cholangitis in erythropoietic protoporphyria mouse model |
| Q34974073 | Red cells from ferrochelatase-deficient erythropoietic protoporphyria patients are resistant to growth of malarial parasites. |
| Q91282530 | Regulation of globin-heme balance in Diamond-Blackfan anemia by HSP70/GATA1 |
| Q88322832 | Reply |
| Q41294557 | Review: molecular pathogenesis of hepatic acute porphyrias. |
| Q94895309 | Role of two nutritional hepatic markers (insulin-like growth factor 1 and transthyretin) in the clinical assessment and follow-up of acute intermittent porphyria patients |
| Q28260693 | Sequential regulation of ferroportin expression after erythrophagocytosis in murine macrophages: early mRNA induction by haem, followed by iron-dependent protein expression |
| Q83394010 | Sideroblastic anemia: molecular analysis of the ALAS2 gene in a series of 29 probands and functional studies of 10 missense mutations |
| Q28270688 | Systematic Analysis of Molecular Defects in the Ferrochelatase Gene from Patients with Erythropoietic Protoporphyria |
| Q92987550 | TSPO2 translocates 5-aminolevulinic acid into human erythroleukemia cells |
| Q77377722 | The penetrance of dominant erythropoietic protoporphyria is modulated by expression of wildtype FECH |
| Q67476187 | Thyroid hormone extraction by plasma exchange: a study of extraction rate |
| Q59590291 | Urinary Metabolic Fingerprint of Acute Intermittent Porphyria Analyzed by 1H NMR Spectroscopy |
| Q24539186 | Variegate porphyria in Western Europe: identification of PPOX gene mutations in 104 families, extent of allelic heterogeneity, and absence of correlation between phenotype and type of mutation |
| Q71808336 | Variegate porphyria: diagnostic value of fluorometric scanning of plasma porphyrins |
| Q83395930 | [Diagnosis of hypochromic microcytic anemia in children] |
| Q83384277 | [Intermittent acute porphyria: a metabolic emergency] |
| Q44115093 | Caroline Schmitt | doctoral advisor | P184 |
| Q3573389 | Yvan Touitou | doctoral student | P185 |
Search more.